News Focus
News Focus
icon url

ORCA

02/23/17 12:57 PM

#28380 RE: ORCA #28379

DRYS $2.33 NOW.I BELIEVE THIS POS WILL SEE ANOTHER BIG RUN.HERE IS WHY.
CHECK DATES BELOW BEFORE IT ROCKED FROM THE LOW OF 1.99$ TO HIGH OF $5.74.WE VERY RECENTLY SAW ANOTHER $200 MILLION SELLING WORTH OF STOCK TO KALANI.RIGHT??I THINK THESE SHARES AND $$ ARE CLOSE TO BE DONE.
NOW READ BELOW WHEN THE NEWS HIT JANUARY 30TH.WHAT HAPPENED TO THE STOCK??IN TWO DAYS IT ROCKED FROM 1.99 TO 5.74.SO EXPECT ANOTHER NEWS WITHIN A COUPLE DAYS THAT THE SHARES ARE SOLD OF THE 200 $ MILLION.
WILL IT HIT $5.74 AGAIN??I DO NOT KNOW.BUT I SEE A REBOUND TO 3.50 AND 4.40.IMO.

Jan 31 2017 5.08 2.64 +108.20% 3.23 5.74 163,953,717
Jan 30 2017 2.44 0.45 +22.61% 1.99 2.65 44,326,318
Prospectus Pursuant to Rule 424(b)(2) (424b2)
Date : 01/30/2017 @ 4:52PM
Between January 23, 2017 and January 30, 2017, we sold pursuant to the Accompanying Prospectus and this Prospectus Supplement 22,539,773 shares of our common stock to Kalani Investments Limited, or the Investor, in connection with the Common Stock Purchase Agreement between us and the Investor dated as of December 23, 2016, which we refer to as the Purchase Agreement, at a price of $3.08 per share. The gross purchase price for these common shares was $69.5 million. Our estimated net proceeds from the sale of these common shares is approximately $68.8 million, after deducting our estimated aggregate offering expenses. We expect to finally settle on this purchase and sale on January 31, 2017.
Between the date of the Purchase Agreement, December 23, 2016, and the date hereof, we have sold, pursuant to the Accompanying Prospectus and this Prospectus Supplement, an aggregate of 31,769,940 shares of our common stock to the Investor at an average price of approximately $6.30 per share. The aggregate gross purchase price for these common shares was $200.0 million. As a result, as of January 31, 2017, we will have completed the sale to the Investor of the full Aggregate Limit (as defined in the Purchase Agreement) provided for under the Purchase Agreement, which will automatically terminate in accordance with its terms. Our estimated aggregate net proceeds from the sale of these common shares is approximately $198.0 million, after deducting our estimated aggregate offering expenses. This information reflects adjustments for the previously announced 1-for-8 reverse stock split of the Company's common shares that became effective as of the opening of trading on January 23, 2017.